NCAM1 has previously been implicated in a number of neuropsychiatric disorders, including schizophrenia [61], and our analysis identifies NCAM1 as another plausible target, despite not being categorized as a GRB target (it’s predictive value is just below the threshold, see Supplementary information). Here, NCAM1 is linked to schizophrenia.